MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202321059408 A) filed by Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, on Sept. 4, 2023, for 'sustained release composition of ruxolitinib.'
Inventor(s) include Arra Ganga, Shrinivas; Wagh, Sanjay; Dhuppad, Ulhas; Haque, Ariful; and Gate, Pradeep.
The application for the patent was published on March 14, under issue no. 11/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a sustained release composition comprising one or more water soluble salt(s) of ruxolitinib, and a means for controlling release of ruxolitinib, the means for controlling release of ruxolitinib are one or more...